About Us

BDS is a science-based GLP immunoassay laboratory specializing only in large-molecule bioanalysis. Our areas of focus include Immunogenicity PK and Neutralizing Antibody assays. Our customer-focused service model allows us to tailor bioanalytical project execution for each client. The team has many years of CRO and industry experience in development and validation of immunoassay methods.

  • The BDS Commitment

    Our focused attention and support on development of large molecule therapeutics allows us to focus on doing a few things, and doing those things very well. We can thereby provide effective and timely communication and guarantee no surprises. As we operate without corporate bureaucracy, we can be responsive to all your project requirements.

  • The BDS Advantage

    After years of working in the CRO space, we have developed a unique model to overcome all normal setbacks experienced by our clients. BDS is equipped to be your true laboratory partner to provide clients with:

    • Customized project and service delivery
    • Scientifically based trouble shooting during all aspects of the project
    • Providing science-backed solutions to move projects forward

Our Team

Dr. Michael Anderson

President, Chief Scientific Officer

Jason Pennucci

Scientific Director

Jason Ambrosius

Director of Laboratory Operations

Lydia Shaffer

RQAP-GLP, RQAP-GCP, COA, CMQ/QE
Director – Quality Assurance

Celeste Rose

RQAP-GLP
Technical Project Support Manager

Margaret Snow

Senior Scientist
Bioanalytical Principal Investigator (PI)

Scot Collins

Senior Scientist
Bioanalytical Principal Investigator (PI)